HIF1A and cancer: Tumour hypoxia is a hallmark of solid tumours and plays a pivotal role in cancer resistance by promoting angiogenesis via the HIF-1α pathway, driving epithelial−mesenchymal transition, invasion, metastasis and stem-like traits, as well as enhancing glycolysis [196].